FIELD: medicine.
SUBSTANCE: invention refers to a composition for cell, tissue and organ preservation containing as an active ingredient indole and indazole compounds of formula (1), or their pharmaceutically acceptable salts or isomers which are effective for prevention of the damage of organs, recovered cell systems or tissues caused by low-temperature storage, transplantation surgery or post-transplantation reperfusion.
EFFECT: invention also refers to a method for preparing said composition.
21 cl, 5 dwg, 6 tbl, 156 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDOLE AND INDAZOLE COMPOUNDS AS CELLULAR NECROSIS INHIBITORS | 2008 |
|
RU2437883C1 |
| INDOLE COMPOUNDS AS CELL NECROSIS INHIBITORS | 2008 |
|
RU2477282C2 |
| GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS ACTIVE INGREDIENT | 2008 |
|
RU2450001C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
| NOVEL COMPOUNDS, ISOMERS THEREOF OR PHARMACUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS | 2007 |
|
RU2448108C2 |
| 2-PYRIDYL-SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS | 2011 |
|
RU2518069C1 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
| THIENO[3,2-d]PYRIMIDINE DERIVATIVES, POSSESSING INHIBITING ACTION WITH RESPECT TO PROTEINKINASE | 2011 |
|
RU2524210C2 |
| QUINAZOLINE DERIVATIVES FOR SLOWING DOWN GROWTH OF CANCER CELLS AND METHOD OF OBTAINING THEM | 2005 |
|
RU2362773C2 |
| NOVEL OXAZOLIDINONE DERIVATIVES WITH CYCLIC AMIDOXIM OR CYCLIC AMIDRAZONE AND CONTAINING THEM PHARMACEUTICAL COMPOSITIONS | 2009 |
|
RU2468023C1 |
